Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Pharmaceuticals
Pharmaceuticals - Indian - Formulations
110 Cr
High Risk
—
43.8
—
5.5
169.00
80.80
Sales CAGR
1Y
37.51%
3Y
—
5Y
—
10Y
—
Profit CAGR
1Y
287.50%
3Y
—
5Y
—
10Y
—
ROE
TTM
15.67%
3Y
42.18%
5Y
—
10Y
—
ROCE
TTM
18.38%
3Y
34.32%
5Y
—
10Y
—
Bearish
1
Neutral
9
Bullish
4
Bearish
12
Neutral
25
Bullish
9
Bearish
11
Neutral
16
Bullish
5
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Performance
MARKET LEADER
Valuation
REASONABLE
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Neutral
Risk
HIGH RISK
Market Cap
₹ 110 Cr
P/E
—